About Semaglutide
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist. It is a 31-amino acid peptide analogue of human GLP-1 with a C18 fatty acid chain attached via a linker to enable extended half-life. Semaglutide was developed for the treatment of type 2 diabetes and obesity.
ShiLai™ Healthcare manufactures Semaglutide by solid-phase peptide synthesis (SPPS) with RP-HPLC purification and LC-MS identity confirmation on every batch. Contact us to discuss B2B supply and OEM requirements.
B2B OEM Projects Only
We are currently not accepting individual or retail customer orders.
Chat on WhatsApp